Fosaprepitant dimeglumine (MK-0517) is a prodrug of Aprepitant . Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV).
体内研究
Fosaprepitant dimeglumine (30 mg/kg; i.p.; daily; for 7 days) attenuates tolerance to morphine and increases the antinociceptive effect in in rats.
Animal Model:
Sprague-Dawley rats
Dosage:
30 mg/kg
Administration:
Intraperitoneal injection, daily, for 7 days
Result:
Increased the antinociceptive effect of morphine compared to control group.
分子式
C37H56F7N6O16P
分子量
1004.83
CAS号
265121-04-8
中文名称
福沙吡坦二甲葡胺
运输条件
Room temperature in continental US; may vary elsewhere.